Peldesine is used for the investigation of cutaneous T-cell lymphoma, psoriasis, and HIV infection; it acts as a potent, competitive, reversible, and orally active inhibitor of purine nucleoside phosphorylase (PNP), and suppresses T-cell proliferation and immune responses in an IL-2-independent manner.